(Q33599203)

English

Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

title

Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story (English)

1 reference

stated in

Europe PubMed Central

28 July 2017

McNeil JJ

1

1 reference

stated in

Europe PubMed Central

PubMed ID

10212650

retrieved

28 July 2017

Grabsch EA

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

10212650

retrieved

28 July 2017

McDonald MM

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

10212650

retrieved

28 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

stated in

Europe PubMed Central

28 July 2017

Medical Journal of Australia

1 reference

stated in

Europe PubMed Central

28 July 2017

170

1 reference

stated in

Europe PubMed Central

28 July 2017

6

1 reference

stated in

Europe PubMed Central

28 July 2017

270-273

1 reference

stated in

Europe PubMed Central

PubMed ID

10212650

retrieved

28 July 2017

Identifiers

PubMed ID

10212650

1 reference

stated in

Europe PubMed Central

PubMed ID

10212650

retrieved

28 July 2017

(Q33599203)

Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)